Decheng Capital »

Genedx Holdings Corp shares owned by Decheng Capital

Quarter-by-quarter ownership of Genedx Holdings Corp (WGS) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Genedx Holdings Corp

Tip: Access up to 7 years of quarterly data

All positions including Genedx Holdings Corp held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genedx Holdings Corp by Decheng Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $285k 104k 2.75

More positions owned by Decheng Capital

Alpine Immune Sciences (ALPN)
Zentalis Pharmaceuticals (ZNTL)
Pacific Biosciences of California (PACB)
10x Genomics Cl A Com (TXG)
ImmunoGen
Arcus Biosciences Incorporated (RCUS)
Karuna Therapeutics Ord
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Illumina (ILMN)
Argenx SE SHS (ARGX)
Acelyrin (SLRN)
Krystal Biotech (KRYS)
Phathom Pharmaceuticals (PHAT)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Terns Pharmaceuticals (TERN)

View all positions for Decheng Capital

Top funds holding Genedx Holdings Corp

Casdin Capital
Corvex Management
Goldman Sachs Group
Blackstone Group
Vanguard Group
Deerfield Management Company
Gagnon Securities
Jacobs Levy Equity Management
Oracle Investment Management
Gagnon Advisors
Millennium Management
Decheng Capital
Tang Capital Management
Soleus Capital Management
Pathstone Holdings

View all funds holding Genedx Holdings Corp